GSK plc (GSK1N)
BMV
Closed
Aug 21, 2026
Day's Range
426.2752 wk Range
356.95Overview - GSK1N - GSK plc
Key Statistics
Valuation
Enterprise Value
39.75T
P/E (Trailing)
‪15.64‬
Price / Sales (TTM)
‪51.42‬
Price / Book
‪4.16‬
EV / EBITDA
‪159.25‬
Profitability
Gross Margin
‪73.05%‬
Profit Margin
‪14.52%‬
Operating Margin
‪30.94%‬
Return on Assets
‪10.00%‬
Return on Equity
‪33.38%‬
Ownership
Shares Outstanding
4.00B
Float
3.88B
Held by Insiders
‪1.74%‬
Held by Institutions
‪48.18%‬
Price stats
Beta
‪0.29‬
50-Day Avg
‪366.65‬
200-Day Avg
‪359.38‬
Dividends
Payout Ratio
‪56.88%‬
Frequency
Quarterly
Peers - GSK1N - GSK plc
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BMV.
- GSK1NBMVGSK plc1.70TMarket Cap+16.26%52-week change15.70P/E (Trailing)‪14.52%‬Profit Margin
- JNJBMVJohnson & Johnson11.05TMarket Cap+27.38%52-week change31.45P/E (Trailing)‪21.48%‬Profit Margin
- ABBVBMVAbbVie Inc.7.94TMarket Cap+13.73%52-week change75.19P/E (Trailing)‪9.80%‬Profit Margin
- MRKBMVMerck & Co., Inc.6.34TMarket Cap+37.98%52-week change121.97P/E (Trailing)‪4.76%‬Profit Margin
- ROP1NBMVRoche Holding AG6.26TMarket Cap+4.75%52-week change25.02P/E (Trailing)‪19.60%‬Profit Margin
- NVNVSNBMVNovartis AG Sponsored ADR5.08TMarket Cap+17.59%52-week change23.87P/E (Trailing)‪22.50%‬Profit Margin
- NOVNNBMVNovartis AG4.94TMarket Cap+13.16%52-week change23.20P/E (Trailing)‪22.50%‬Profit Margin
Profile Summary - GSK1N - GSK plc
About
GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, England. The company focuses on discovering, developing, and manufacturing prescription medicines and vaccines for a wide range of diseases. GSK plc operates as a focused biopharma business, with research and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
